Genomic Health, Inc. , provider of the Oncotype DX® breast cancer assay, today announced results of two separate studies presented at the annual meeting of the American Society of Clinical Oncology , that could lead to the development of new tests for predicting benefit from certain targeted therapies in cancer, specifically cetuximab for colon cancer and docetaxel for breast cancer.
Colon cancer patients treated with Genentech Inc's Avastin and chemotherapy lived longer without their disease getting worse than those who were also treated with ImClone Systems Inc's Erbitux, according to a study presented on Saturday.
Paul Sibley was worried about a family history of colon cancer when cancer hit him from a different direction. What he thought would be a minor procedure on Jan. 9, 2006, to remove some squamous cells in his face turned out to be 12 hours of surgery to remove skin cancer.
Skin cancer can be bad enough by itself, but for some people it may just be a sign of other trouble to come. Medical reporter John Hammarley explains.
People with advanced colon cancer who have smoked cigarettes or used other tobacco products for many years may have an increased risk that their colon cancer will return, according to research by Dana-Farber Cancer Institute scientists.
Contact:
Copyright © 2005 Colon Cancer Solutions.com All Rights Reserved